Compare IXHL & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IXHL | ACCL |
|---|---|---|
| Founded | 2001 | 2009 |
| Country | Australia | Hong Kong |
| Employees | N/A | N/A |
| Industry | | Professional Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4M | 36.3M |
| IPO Year | 2024 | 2024 |
| Metric | IXHL | ACCL |
|---|---|---|
| Price | $1.96 | $2.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 69.0K | 2.4K |
| Earning Date | 11-24-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $1.23 |
| 52 Week High | $6.39 | $4.98 |
| Indicator | IXHL | ACCL |
|---|---|---|
| Relative Strength Index (RSI) | 21.19 | 40.17 |
| Support Level | $0.20 | $1.32 |
| Resistance Level | $3.82 | $2.89 |
| Average True Range (ATR) | 0.19 | 0.09 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 6.02 | 18.33 |
Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.